Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,406 public trials 661 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

A Study of Long-Term Responders on Olaparib

NCT02489058

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • South Eastern Sydney Local Health District Randwick, New South Wales, Australia
  • British Columbia Cancer Centre Vancouver, British Columbia, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

NCT03398655

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • UAB Division of GYN Oncology Birmingham, Alabama, United States
  • Western Regional Medical Center Goodyear, Arizona, United States
  • Arizona Oncology Associates, PC - HAL - USO Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL - USO Tempe, Arizona, United States
View all 94 locations
View Trial Details
Completed

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

NCT02963831

Conditions
Adnexal Diseases, Appendiceal Cancer, Appendiceal Neoplasms, +27 more
Locations
  • Research Facility San Diego, California, United States
  • Research Facility Miami, Florida, United States
  • Research Facility Buffalo, New York, United States
  • Research Facility New York, United States
View Trial Details
Completed

HE4 as a Relapse Biomarker in Ovarian Cancers

NCT02595281

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • BENGRINE-LEVEVRE Leïla Dijon, Centre Georges François Leclerc, France
  • DEMARCHI Martin Strasbourg, Centre Paul Strauss, France
  • LONGO Raphaelle Metz, CHU Metz Thionville, France
  • KURTZ Jean-Emmanuel Strasbourg, Hôpital Civil, France
View Trial Details
Completed

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

NCT02657889

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +27 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 30 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions